Are you Dr. Falloon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7600 Shadywood Rd
Bethesda, MD 20817Phone+1 301-299-2922
Summary
- Dr. Judith Falloon, MD is an infectious disease specialist in Bethesda, Maryland. She is currently licensed to practice medicine in Maryland.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1983 - 1987
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1980 - 1983
University of Maryland School of MedicineClass of 1980
Certifications & Licensure
MD State Medical License 1980 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age Start of enrollment: 2007 Oct 01
- A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age Start of enrollment: 2009 Mar 01
- A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsEfficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.Cory Perugino, Emma L Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della-Torre
Rheumatology and Therapy. 2023-12-01 - 8 citationsThe MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep...Alan Kivitz, Liangwei Wang, Ilias Alevizos, Michele Gunsior, Judith Falloon
RMD Open. 2023-08-01 - 21 citationsA prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.Lauren A Chang, Emily Phung, Michelle C Crank, Kaitlyn M Morabito, Tonya Villafana
Science Translational Medicine. 2022-12-21
Grant Support
- HIV Infection: Therapy And ComplicationsNational Institute Of Allergy And Infectious Diseases2001–2002
- HIV Therapy And Its ComplicationsNational Institute Of Allergy And Infectious Diseases2000
